January 6, 2014 / 12:26 PM / 4 years ago

Thermo Fisher sells cell culture, other businesses to GE

Jan 6 (Reuters) - Scientific and laboratory equipment maker Thermo Fisher Scientific Inc said it would sell its cell culture, gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Co, for about $1.06 billion.

The businesses, expected to have combined revenue of about $250 million in 2013, will become part of GE Healthcare’s life sciences division, Thermo Fisher said in a statement.

The deal will allow GE to expand its technologies for the discovery and manufacturing of medicines, vaccines and diagnostics, GE said in a separate statement.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below